Welcome
Home arrow Program
Print E-mail
:: Scientific Program ::


:: Program at a glance ::

Wednesday, September 6, 2006
16:00 - 18:00 Registration
19:00 Welcome Reception
 
Thursday, September 7, 2006Friday, September 8, 2006Saturday, September 9, 2006
8:30 - 12:30
From bench to bedside :
where are we going ?


 14:00 - 17:30
How to improve patient management and quality of life ?

15:30 - 16:30
Poster Session
 
8:30 - 13:00
NF2 tumour management :
towards the end of the preconceived ideas


14:00 - 17:30
Auditory Rehabilitation

 
20:00
Gala Dinner
8:30 - 13:00
New perspectives in Auditory Brainstem Implant

13:00 - 13:15
Closing remarks




:: Detailed Program :: 

Thursday, September 7, 2006

:: Session 1 - From bench to bedside : where are we going ? ::
Chairmen : Marco GIOVANNINI (Inserm U674, Paris, France)/ D.Gareth R. EVANS (St Mary’s Hospital, Manchester, UK)

8:30 Welcome/Introduction
Michel Kalamarides (Beaujon Hospital, Clichy, France)
Olivier Sterkers (
Beaujon Hospital, Clichy, France)
8:35 NF2 : a genetic and clinical overview
D. Gareth R. Evans (St Mary’s Hospital, Manchester, UK)
9:35 Relevance of mosaicism in NF2
Victor F. Mautner (University Hospital Eppendorf, Hamburg, Germany)
10:00 Pathology of Vestibular Schwannomas : Results of the NF2 Natural History Study
Anat O. Stemmer-Rachamimov (MGH, Boston, USA)

10:30 Coffee break

11:00 The NF2 tumor suppressor, Merlin, in membrane organization and tumorigenesis.
Andrea I. McClatchey (MGH, Boston, USA)
11:30 Understanding NF2 : insights from mouse models.
Marco Giovannini (Inserm U674, Paris, France)
12:00 Therapeutic Development in NF2 : A Status Report
Allan E. Rubenstein(NexGenix Pharmaceuticals)
Rui-Hong Chen (NexGenix Pharmaceuticals)


12:30-14:00 Lunch

:: Session 2 - How to improve patient management and quality of life ? ::
Chairmen : William H. SLATTERY III (HEI, Los Angeles, USA) / Bernard FRAYSSE (Purpan Hospital, Toulouse, France)

14:00 Conventional and Advanced Imaging of NF2: Pearls and Pitfalls.
Michael H. Lev (MGH, Boston, USA)
14:30 Natural history of NF2: lessons on NF2 patient management.
William H. Slattery III (HEI, Los Angeles, USA)
15:00 Psychosocial aspects of NF2-responses from patients and significant others
Wanda Neary (St Mary’s Hospital, Manchester, UK)

15:30 - 16:30 Poster Session

16:30 Discussion on clinical cases with panel
Michael H. Lev, Victor F. Mautner, Wanda Neary, Marc Sanson, Vincent Darrouzet.
Moderators: D. Gareth R. Evans(St Mary’s Hospital, Manchester, UK), William H. Slattery III (HEI, Los Angeles, USA)


Friday, September 8, 2006

:: Session 3 - NF2 tumour management : towards the end of the preconceived ideas ::
Chairmen : Peter Mclaren BLACK (BWH, Boston, USA)/ Richard T. RAMSDEN (Manchester Royal Infirmary, Manchester, UK)

8:30 Tumour surgical strategy in NF2
Michel Kalamarides (Hôpital Beaujon, Clichy, France)
8:45 Meningioma : a crucial tumour in NF2
Peter Mclaren Black (BWH, Boston, USA)
9:15 How, when and why surgically treating NF2 spinal tumours ?
Jacques Brotchi (Erasme Hospital, Brussels, Belgium)
Florence Lefranc (Erasme Hospital, Brussels, Belgium)
9:45 Radiosurgery : defining a key role
Jean Regis (Timone Hospital, Marseille, France)
10:15 Trans-labyrinthine approach for NF2-vestibular schwannoma
Richard T. Ramsden (Manchester Royal Infirmary, Manchester, UK)

10:30 Coffee break

11:00 Middle fossa approach for NF2 vestibular schwannoma
William H. Slattery III (HEI, Los Angeles, USA)
11:15 Retrosigmoid approach for NF2 vestibular schwannoma
Vittorio Colletti (University of Verona, Verona, Italy)
11:30 Discussion on clinical cases with panel
DGR Evans, PM Black, J Brotchi, J Regis, RT Ramsden, WH Slattery III, V Colletti
Moderators: Olivier Sterkers (Beaujon Hospital, Clichy, France)/ Michel Kalamarides (Beaujon Hospital, Clichy, France)

13:00-14:00 Lunch

:: Session 4 - Auditory Rehabilitation ::
Chairmen : Thomas LENARZ (Medical University of Hannover, Hannover, Germany), Gerard O’ DONOGHUE (University of Nottingham, Nottingham, UK)

14:00 Auditory brainstem implant : past, present, future
Robert V. Shannon (HEI, Los Angeles, USA)
14:30 Auditory neuroplasticity
Lionel Collet (Edouard Herriot Hospital, Lyon, France)
 Hung Thai-Van (Edouard Herriot Hospital, Lyon, France)
15:00 Functional Imaging of auditory pathways
TBD
15:30 Auditory brainstem implants : clinical results
Roland Laszig (University of Freiburg, Freiburg, Germany)

16:00 Coffee break 

16:30 ABI implantation : surgical technique and anatomical factors
Wolf-Peter Sollmann (Städtisches Klinikum Braunschweig, Braunschweig, Germany)
 17:00 ABI Implantation : pre-operative prognostic factors (size, duration of deafness, side…)
William H. Slattery III (HEI, Los Angeles, USA)
 

Saturday, September 9, 2006

:: Session 5 - New perspectives in Auditory Brain Implant ::
Chairmen : Vittorio COLLETTI (University of Verone, Verone, Italy)/ Wolf Peter SOLLMANN (Städtisches Klinikum Braunschweig, Braunschweig, Germany)

8:30 The Penetrating-electrode Auditory Brainstem Implant (PABI)
Robert V. Shannon (HEI, Los Angeles, USA)
8:55 Sleeper or not ?
Richard Ramsden (Manchester Royal Infirmary, Manchester, UK)
9:20 Non NF2-ABI indications
Olivier Sterkers (Beaujon Hospital, Clichy, France)
9:45 ABI in Children
Vittorio Colletti (University of Verona, Verona, Italy)
10:05 Digisonic ABI in NF2
Christophe Vincent (Roger Salengro Hospital, Lille, France)

10:30 Coffee break

11:00 New developments in ABI implantation
Manuel Manrique (University of Navarra, Pamplona, Spain)
11:30 Medel experience
Robert Behr (Neurosurgery Clinic of University Marburg, Fulda, Germany)
12:00 Present indications of ABI in NF2 patients - The auditory midbrain implant as an alternative
Thomas Lenarz (Medical University of Hannover, Hannover, Germany) 
12:30 Bilateral Cochlear Nerve Aplasia : an indication for ABI?
F. Erwin Offeciers (Wilrijk Antwerp University, Antwerp, Belgium) 
13:00 Closing remarks
Michel Kalamarides (Beaujon Hospital, Clichy, France)
Olivier Sterkers (Beaujon Hospital, Clichy, France) 


Last Updated ( Saturday, 29 July 2006 )